RegentAtlantic Capital’s DexCom DXCM Stock Holding History

RegentAtlantic Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.52M	Buy	18,871 +1,735	+10%	+$147K	0.05%	242
2022 Q2	$1.28M	Buy	17,136 +1,224	+8%	+$112K	0.04%	268
2022 Q1	$2.04M	Sell	15,912 -1,860	-10%	-$203K	0.06%	220
2021 Q4	$2.39M	Buy	17,772 +1,936	+12%	+$278K	0.07%	200
2021 Q3	$2.17M	Buy	15,836 +3,160	+25%	+$399K	0.07%	203
2021 Q2	$1.35M	Buy	12,676 +3,800	+43%	+$365K	0.04%	253
2021 Q1	$797K	Buy	8,876 +1,072	+14%	+$101K	0.03%	308
2020 Q4	$721K	Sell	7,804 -5,576	-42%	-$498K	0.03%	283
2020 Q3	$1.38M	Buy	+13,380	New	+$1.4M	0.06%	194

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RegentAtlantic Capital's DXCM Position: Q3 2022 in Review

RegentAtlantic Capital increased its DexCom (DXCM) stake by 10% in Q3 2022, buying an estimated $147K and bringing the position to 18,871 shares worth $1.52M. The position accounts for 0.05% of the portfolio, ranked #242.

RegentAtlantic Capital first reported a position in DXCM in Q3 2020 and has held it in 9 quarters since. The position peaked at $2.39M in Q4 2021. 794 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

RegentAtlantic Capital held 18,871 shares of DexCom worth $1.52M as of Q3 2022.
RegentAtlantic Capital bought 1,735 DexCom shares in Q3 2022, an estimated $147K.
DexCom made up 0.05% of RegentAtlantic Capital's portfolio in Q3 2022, its #242 holding.
RegentAtlantic Capital first reported a position in DexCom in Q3 2020 and has held it in 9 quarters since.
RegentAtlantic Capital's DexCom position peaked at $2.39M in Q4 2021.
794 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.